Document is current
Any future updates will be listed below
-
Authors
Kulkarni, Aishwarya https://orcid.org/0000-0001-5365-214X
Mohan, Varshini https://orcid.org/0009-0006-0774-4223
Tang, Tracy T https://orcid.org/0000-0003-3425-4263
Post, Leonard
Chan, Yih-Chih
Manning, Murray
Thio, Niko https://orcid.org/0000-0002-3089-0871
Parker, Benjamin L
Dawson, Mark A
Rosenbluh, Joseph
Vissers, Joseph HA https://orcid.org/0000-0003-0435-6824
Harvey, Kieran F https://orcid.org/0000-0001-7845-369X
-
Funding
Funding for this research was provided by:
DHAC | National Health and Medical Research Council (APP1078220)
DHAC | National Health and Medical Research Council (APP1194467)
CCA | Cancer Council Victoria (APP1157737)
Peter MacCallum Cancer Foundation (NA)
Peter MacCallum Cancer Foundation (NA)
Rosie Lew Peter MacCallum Cancer Foundation Postgraduate Award (NA)
Australian Cancer Research Foundation (NA)
Australian Government Research Training Program Scholarship
- License Information
-
More Information
Article History
Received: 27 June 2024
Revised: 11 July 2024
Accepted: 17 July 2024
First Online: 5 August 2024
Disclosure and competing interests statement
: TT Tang and L Post report employment with Vivace Therapeutics and have equity interest in Vivace Therapeutics.
